Oxford Cancer Analytics Appoints Dr. Heinrich Roder as Senior Vice President, Research & Development
Company
Oxford Cancer Analytics
OxfordBiotechnologyHealth CareArtificial IntelligenceHealth DiagnosticsDescription
OXcan has raised US$11 million in Series A funding, and appointed Dr. Heinrich Roder as Senior Vice President, Research & Development. The funding positions the company to develop and globally commercialize its new generation of minimally invasive liquid biopsy blood tests for the early detection of lung cancer.
Quick answer
Oxford Cancer Analytics Appoints Dr. Heinrich Roder as Senior Vice President, Research & Development (January 9, 2025). Oxford Cancer Analytics is based in Oxford, England, United Kingdom.
- What did Oxford Cancer Analytics announce on January 9, 2025?
- OXcan has raised US$11 million in Series A funding, and appointed Dr. Heinrich Roder as Senior Vice President, Research & Development. The funding positions the company to develop and globally commercialize its new generation of minimally invasive liquid biopsy blood tests for the early detection of lung cancer.
- What does Oxford Cancer Analytics do?
- Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection.
- Where is Oxford Cancer Analytics based?
- Oxford Cancer Analytics is based in Oxford, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Eko Health (January 9, 2025), NeoGenomics (January 10, 2025), Alltrna (January 6, 2025) and MedQuest Associates (January 13, 2025) also announced leadership changes within 45 days of Oxford Cancer Analytics.
Source: Fundz verified event record.
Other recent leadership changes in Health Diagnostics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Eko Health Appoints Justin Spencer as Chief Financial Officer (January 9, 2025)
- NeoGenomics Appoints Tony Zook as Chief Executive Officer (CEO) to Succeed Chris Smith (January 10, 2025)
- Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer (CMO) (January 6, 2025)
- MedQuest Associates Appoints Warren Christopher ‘Chris’ Shea as Chief Legal Officer (January 13, 2025)
- Emmes Group Appoints Germaine Gross as Chief Commercial Officer of Emmes Biopharma (January 16, 2025)
- Ulvera AI Appoints Domenic Serafino as Chief Executive Officer and Co-Founder (January 21, 2025)
Who to call at Oxford Cancer Analytics, and when
A new leader at Oxford Cancer Analytics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oxford Cancer Analytics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oxford Cancer Analytics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oxford Cancer Analytics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oxford Cancer Analytics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oxford Cancer Analytics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.